Sunday 11 October 2026
Export all ABBV data to Excel Powerpack
AbbVie Inc.
ABBV Healthcare Drug Manufacturers General
AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
276.47
4.05
+1.49%
Follow ABBV
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
17.19 | 29.91 | 25.75 | 16.77 | 37.47 | 20.99 | 24.57 | 58.54 | 74.04 | 96.82 |
Piotroski F-Score |
6 | 5 | 7 | 7 | 4 | 6 | 8 | 5 | 5 | 8 |
P/S ratio |
3.95 | 5.57 | 4.34 | 3.94 | 3.90 | 4.26 | 4.95 | 5.20 | 5.58 | 6.61 |
Altman Z-Score |
2.05 | 2.44 | 2.24 | 2.19 | 1.31 | 1.85 | 2.30 | 1.98 | 1.87 | 2.31 |
Altman Z″-Score (non-manufacturers) |
1.88 | 1.66 | 0.74 | 3.56 | 0.43 | 0.69 | 1.09 | 0.46 | (0.35) | (0.34) |
P/FCF ratio |
15.43 | 16.65 | 11.11 | 10.27 | 10.64 | 10.90 | 11.86 | 12.81 | 17.63 | 22.69 |
Beneish M-Score |
(2.45) | (2.73) | (3.15) | (2.92) | (1.90) | (2.72) | (2.84) | (3.08) | (3.08) | (2.85) |
P/Operating CF |
65.69 | 60.78 | 41.88 | 40.04 | 36.80 | 47.22 | 38.72 | 59.45 | 44.60 | 77.46 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 44 |
P/B ratio |
21.84 | 30.81 | 0.00 | 0.00 | 13.64 | 15.53 | 16.64 | 27.18 | 93.45 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.13 | 6.54 | 5.32 | 4.75 | 5.59 | 5.45 | 5.88 | 6.06 | 6.67 | 7.63 |
EV/EBITDA |
12.50 | 16.72 | 21.39 | 10.53 | 14.37 | 11.59 | 12.85 | 12.81 | 17.09 | 19.39 |
EV/Operating CF |
18.70 | 18.54 | 12.98 | 11.85 | 14.57 | 13.46 | 13.70 | 14.41 | 19.99 | 24.51 |
EV/FCF |
20.06 | 19.58 | 13.63 | 12.37 | 15.26 | 13.94 | 14.09 | 14.92 | 21.08 | 26.18 |
Quick Ratio |
1.14 | 0.89 | 0.78 | 2.91 | 0.60 | 0.56 | 0.69 | 0.63 | 0.43 | 0.41 |
Current Ratio |
1.65 | 1.28 | 0.98 | 3.18 | 0.84 | 0.79 | 0.96 | 0.87 | 0.66 | 0.67 |
Net Debt/EBITDA |
2.89 | 2.50 | 3.96 | 1.79 | 4.35 | 2.53 | 2.03 | 1.81 | 2.80 | 2.59 |
Debt/Assets |
55.74% | 52.79% | 67.92% | 74.88% | 57.16% | 52.33% | 45.58% | 44.08% | 49.68% | 50.39% |
Debt/Equity |
7.95 | 7.33 | (4.77) | (8.17) | 6.57 | 4.97 | 3.66 | 5.71 | 19.96 | (20.91) |
Asset Turnover |
0.43 | 0.41 | 0.50 | 0.45 | 0.38 | 0.38 | 0.41 | 0.40 | 0.42 | 0.45 |
Operating CF/Net income |
1.18 | 1.88 | 2.36 | 1.69 | 3.81 | 1.97 | 2.12 | 4.74 | 4.44 | 4.55 |
Capex/Depreciation |
(0.40) | (0.35) | (0.36) | (0.27) | (0.12) | (0.09) | (0.08) | (0.06) | (0.08) | (0.14) |
Interest Coverage |
9.68 | 9.51 | 5.58 | 8.60 | 4.98 | 7.52 | 8.86 | 7.58 | 4.23 | 5.74 |
| 138.75% | 109.09% | (339.62%) | (94.86%) | 187.45% | 80.90% | 72.01% | 34.82% | 61.59% | 6,155.88% | |
| 9.99% | 7.76% | 8.74% | 10.62% | 3.85% | 7.77% | 8.26% | 3.52% | 3.14% | 3.11% | |
ROIC |
16.65% | 18.26% | 16.76% | 43.55% | 7.83% | 13.61% | 15.87% | 14.00% | 8.79% | 15.97% |
Return on Tangible Assets |
66.07% | 71.89% | 219.66% | 21.36% | 607.37% | (535.34%) | 305.23% | 3,213.33% | (52.76%) | (48.68%) |
Average Days of Receivables |
67.74 | 65.82 | 60.00 | 59.56 | 70.30 | 64.80 | 70.76 | 74.96 | 70.75 | 75.13 |
Research and Development Expense of Revenue |
17.10% | 17.75% | 31.54% | 19.26% | 13.93% | 12.32% | 11.21% | 14.13% | 22.71% | 14.87% |
Selling, General and Administrative Expense of Revenue |
22.94% | 22.31% | 22.59% | 20.87% | 24.67% | 21.97% | 26.29% | 23.70% | 26.19% | 22.91% |
Intangible Assets out of Total Assets |
0.67 | 0.61 | 0.62 | 0.38 | 0.77 | 0.74 | 0.72 | 0.65 | 0.70 | 0.66 |
Share Based Compensation of Revenue |
1.38% | 1.29% | 1.29% | 1.29% | 1.64% | 1.23% | 1.16% | 1.38% | 1.62% | 1.56% |
Graham Net Nets |
(0.45) | (0.28) | (0.36) | (0.36) | (0.63) | (0.43) | (0.32) | (0.32) | (0.34) | (0.27) |
Graham Number |
15.28 | 15.38 | 0.00 | 0.00 | 22.49 | 35.58 | 38.10 | 19.01 | 10.13 | 0.00 |
Earnings Yield |
5.82% | 3.34% | 3.88% | 5.96% | 2.67% | 4.76% | 4.07% | 1.71% | 1.35% | 1.03% |
Free Cash Flow Yield |
6.48% | 6.00% | 9.00% | 9.74% | 9.40% | 9.18% | 8.43% | 7.81% | 5.67% | 4.41% |
Revenue per Share |
15.81 | 17.68 | 21.25 | 22.46 | 27.48 | 31.75 | 32.78 | 30.72 | 31.85 | 34.57 |
Operating CF per Share |
4.34 | 6.24 | 8.71 | 9.00 | 10.55 | 12.87 | 14.08 | 12.92 | 10.63 | 10.76 |
Capex per Share |
(0.30) | (0.33) | (0.41) | (0.37) | (0.48) | (0.44) | (0.39) | (0.44) | (0.55) | (0.69) |
Free Cash Flow per Share |
4.05 | 5.91 | 8.30 | 8.62 | 10.07 | 12.42 | 13.69 | 12.48 | 10.08 | 10.07 |
Cash per Share |
3.96 | 6.13 | 5.23 | 26.96 | 5.09 | 5.55 | 5.21 | 7.25 | 3.14 | 2.97 |
Shareholders Equity per Share |
2.86 | 3.19 | (5.48) | (5.52) | 7.86 | 8.72 | 9.76 | 5.88 | 1.90 | (1.82) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.86 | 3.19 | (5.48) | (5.52) | 7.86 | 8.72 | 9.76 | 5.88 | 1.90 | (1.82) |
Free Cash Flow |
6,562.00 | 9,431.00 | 12,789.00 | 12,772.00 | 16,790.00 | 21,990.00 | 24,248.00 | 22,062.00 | 17,832.00 | 17,816.00 |
Working Capital |
6,406.00 | 4,582.00 | (294.00) | 33,934.00 | (4,488.00) | (7,266.00) | (1,075.00) | (4,839.00) | (13,167.00) | (14,227.00) |
Capital Expenditures |
(479.00) | (529.00) | (638.00) | (552.00) | (798.00) | (787.00) | (695.00) | (777.00) | (974.00) | (1,214.00) |
Net Current Asset Value |
(45,276.00) | (44,466.00) | (50,853.00) | (47,768.00) | (113,295.00) | (103,165.00) | (93,055.00) | (91,312.00) | (106,215.00) | (108,126.00) |
EV/EBIT |
14.10 | 19.34 | 27.31 | 12.16 | 22.55 | 17.10 | 18.86 | 25.80 | 41.14 | 30.94 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Price to Operating Income |
10.84 | 16.45 | 22.26 | 10.10 | 15.72 | 13.37 | 15.87 | 22.15 | 34.40 | 26.81 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.46 | 0.54 | 0.61 | 0.68 | 1.23 | 1.67 | 1.72 | 2.59 | 2.51 | 1.60 |
Cash ROIC |
13.70% | 18.05% | 32.03% | 12.97% | 15.60% | 21.57% | 27.01% | 26.71% | 23.44% | 25.63% |
Accounts Receivable Turnover |
5.40 | 5.73 | 6.26 | 6.15 | 6.43 | 5.98 | 5.47 | 4.85 | 5.10 | 5.20 |
Accounts Payable Turnover |
0.65 | 0.72 | 0.70 | 0.63 | 0.96 | 0.81 | 0.72 | 0.73 | 0.54 | 0.55 |
Inventory Turnover |
3.69 | 4.62 | 4.81 | 4.35 | 6.01 | 5.42 | 5.19 | 5.32 | 4.08 | 3.99 |
Average Days of Payables |
586.99 | 530.03 | 564.24 | 580.55 | 478.20 | 474.90 | 532.43 | 547.99 | 689.77 | 696.44 |
Days of Inventory on Hand |
90.37 | 83.19 | 75.90 | 88.96 | 78.52 | 65.44 | 75.02 | 73.29 | 90.28 | 99.27 |
Average Receivables |
4,744.00 | 4,923.00 | 5,236.00 | 5,406.00 | 7,125.00 | 9,399.50 | 10,615.50 | 11,204.50 | 11,037.00 | 11,754.00 |
Average Payables |
8,921.00 | 9,802.50 | 11,078.50 | 11,881.50 | 15,995.50 | 21,429.00 | 24,050.50 | 28,026.00 | 31,297.50 | 33,339.50 |
Average Inventory |
1,581.50 | 1,524.50 | 1,605.00 | 1,709.00 | 2,561.50 | 3,219.00 | 3,353.50 | 3,839.00 | 4,140.00 | 4,566.00 |
Average Assets |
59,574.50 | 68,442.50 | 65,069.00 | 74,233.50 | 119,840.00 | 148,547.00 | 142,667.00 | 136,758.00 | 134,936.00 | 134,560.50 |
Average Common Equity |
4,290.50 | 4,866.50 | (1,674.50) | (8,309.00) | 2,462.50 | 14,266.50 | 16,361.50 | 13,842.00 | 6,880.50 | 68.00 |
Columns are period end dates